Lifeward Ltd.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $22.0M | $25.7M | $13.9M | $5.5M | $6.0M |
| Cost of revenue | $13.6M | $17.4M | $9.4M | $3.6M | $3.1M |
| Gross profit | $8.4M | $8.2M | $4.5M | $1.9M | $2.9M |
| Research and development | $3.2M | $4.6M | $4.1M | $4.0M | $2.9M |
| Operating expenses | $28.1M | $37.6M | $28.1M | $21.0M | $15.6M |
| Operating income | -$19.7M | -$29.3M | -$23.6M | -$19.1M | -$12.7M |
| Pretax income | -$20.0M | -$28.9M | -$22.1M | -$19.1M | -$12.6M |
| Income tax expense | -$55,000 | $43,000 | -$12,000 | $467,000 | $94,000 |
| Net income | -$19.9M | -$28.9M | -$22.1M | -$19.6M | -$12.7M |
| Balance Sheet | |||||
| Cash and equivalents | $2.2M | $6.7M | $28.1M | $67.9M | $88.3M |
| Current assets | $15.8M | $21.3M | $39.2M | $72.5M | $92.5M |
| Total assets | $22.9M | $30.5M | $63.2M | $74.2M | $94.8M |
| Current liabilities | $12.0M | $10.2M | $11.8M | $4.8M | $4.0M |
| Total liabilities | $14.5M | $11.6M | $16.7M | $6.1M | $5.4M |
| Stockholders' equity | $8.4M | $18.8M | $46.5M | $68.2M | $89.4M |
| Cash Flow Statement | |||||
| Cash from operations | -$16.8M | -$21.7M | -$20.7M | -$17.9M | -$11.5M |
| Depreciation and amortization | $333,000 | $494,000 | $239,000 | $202,000 | $266,000 |
| Stock-based compensation | $743,000 | $1.3M | $1.3M | $993,000 | $833,000 |
| Capital expenditure | $16,000 | $0 | $81,000 | $25,000 | $47,000 |
| Free cash flow | -$16.8M | -$21.7M | -$20.7M | -$17.9M | -$11.5M |
| Impairments | $2.8M | $9.8M | $0 | $0 | — |
Shares outstanding 2.8M
Annual filing data through FY ended December 31, 2025; float as of July 14, 2026.